TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

Translational Breast Cancer Research Consortium

研究成果: Article同行評審

20 引文 斯高帕斯(Scopus)

指紋 深入研究「TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer」主題。共同形成了獨特的指紋。

Medicine & Life Sciences